Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir for the Prevention of Herpes Simplex Virus Transmission
NCT00001649Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 1997
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of valaciclovir in genital herpes, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 1997; status: completed.
02
Drugs
valaciclovir
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT00001649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001649.